MDLinx Endocrinology Overview: Our medical editors have ranked and organized papers in the top peer-reviewed clinical journals by topic including diabetes types 1 and 2, thyroid and glandular diseases, obesity and dyslipidemia. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
Also on this page: MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, and clinical pearls from The Smartest Diabetes Expert as well as endocrinology topics in The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Endocrinology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Diabetes is not a risk factor for HCC
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Thyroid Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
921 Effects of Serum n-3 to n-6 Polyunsaturated Fatty Acids Ratios on Coronary Atherosclerosis in Statin-Treated Patients With Coronary Artery Disease The American Journal of Cardiology, December 20, 2012 Clinical Article
922 Association of physical activity volume and hypercholesterolemia in US adults QJM: An International Journal of Medicine, December 20, 2012
923 Assessment of motivation of the patients with atherosclerosis of the lower limbs to stop smoking Surgical and Vascular Nursing , December 20, 2012
924 Life course body mass index, birthweight and lipid levels in mid-adulthood: a nationwide birth cohort study European Heart Journal, December 19, 2012 Clinical Article
925 Fasting Time and Lipid Levels in a Community-Based Population A Cross-sectional Study Fasting Time and Lipid Levels JAMA Internal Medicine, December 19, 2012
926 Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study Full Text Cardiovascular Diabetology, December 19, 2012
927 Synergistic Effects of Serum Uric Acid and Cardiometabolic Risk Factors on Early Stage Atherosclerosis: The Cardiometabolic Risk in Chinese Study PLOS ONE, December 19, 2012
928 Low-density lipoprotein cholesterol control rates in the type-2 diabetic patient population within independent nurse practitioner settings Journal of the American Academy of Nurse Practitioners, December 18, 2012
929 Management of Inherited Atherogenic Dyslipidemias in Children Therapeutic Apheresis and Dialysis, December 18, 2012
930 Prevalence of Dyslipidemia and Lipid Goal Attainment in Statin-Treated Subjects From 3 Data Sources: A Retrospective Analysis Full Text Journal of the American Heart Association, December 18, 2012 Clinical Article
931 Treatment Targets in the Management of Dyslipidemias Current Cardiology Reports, December 17, 2012 Clinical Article
932 Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation American Journal of Physiology - Endocrinology and Metabolism, December 17, 2012
933 Regulation of lipid metabolism-related gene expression in whole blood cells of normo- and dyslipidemic men after fish oil supplementation Full Text Lipids in Health and Disease, December 17, 2012 Clinical Article
934 Targeting High Density Lipoproteins in the Prevention of Cardiovascular Disease Current Cardiology Reports, December 14, 2012
935 Update on guidelines for management of hypercholesterolemia Expert Review of Cardiovascular Therapy , December 14, 2012
936 Emergent cardiovascular risk factors in the very elderly Expert Review of Cardiovascular Therapy , December 14, 2012
937 Prevention of Post–Coronary Artery Bypass Grafting (CABG) Atrial Fibrillation: Efficacy of Prophylactic Beta-Blockers in the Modern Era Annals of Noninvasive Electrocardiology, December 14, 2012 Clinical Article
938 Aortic Distensibility and Aortic Intima-Media Thickness in Patients without Clinical Manifestation of Atherosclerotic Cardiovascular Disease Echocardiography, December 14, 2012
939 Management of Dyslipidemias in the Presence of the Metabolic Syndrome or Type 2 Diabetes Current Cardiology Reports, December 13, 2012 Clinical Article
940 Dyslipidemias in the Prevention of Cardiovascular Disease: Risks and Causality Current Cardiology Reports, December 13, 2012 Clinical Article
As published in Pancreas, researchers at the Bowman Gray School of Medicine have identified a protein (islet homeostasis protein [IHoP]) which appears to control blood glucose levels by regulating the balance between insulin and glucagon. IHoP is released from glucagon-producing cells in the islets. In both humans and animals, high levels of IHoP exist in the euglycemic state, while T1DM is associated with an absence of IHoP. The authors suggest that IHoP may serve as a target in the treatment of T1DM.
Read the article summaryAs reported in the Archives of Internal Medicine, researchers at the Mayo Clinic have shown an association between statin use and diabetes mellitus in postmenopausal women. The study involved 161,808 postmenopausal women (age range, 50-79 years) who were enrolled at 40 centers between 1993 and 1998 as part of the Women’s Health Initiative. Of the study cohort, data was available for 153,840 women without diabetes at baseline, 7.04% of whom used statins. There were 10,242 incident cases of diabetes in statin users (HR = 1.71) during 1,004,466 person-years of follow-up
Read the article summaryAnthropometric, laboratory, and clinical findings were evaluated in 681 patients with type 2 diabetes mellitus to determine the factors with the greatest influence on determining the basal insulin dosage for a target glucose level < 120 mg/dL. The authors reported that waist circumference, the duration of insulin treatment, lipid-lowering medications, use of insulin sensitizers, the HbA1c, fasting plasma glucose, HDL-C, and triglycerides levels, and severe NAFLD were most significant.
Read the article summary1 Meta-Analysis of Impact of Different Types and Doses of Statins on New-Onset Diabetes Mellitus The American Journal of Cardiology, April 4, 2013 Evidence Based Medicine Review Article
2 Walking Versus Running for Hypertension, Cholesterol, and Diabetes Mellitus Risk Reduction Arteriosclerosis, Thrombosis, and Vascular Biology, April 17, 2013
3 Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations The Lancet, March 26, 2013
4 Relationship between Milk and Calcium Intake and Lipid Metabolism in Female Patients with Type 2 Diabetes Yonsei Medical Journal, April 8, 2013 Free full text
5
Intensive treatment of persistent microalbuminuria: determinants of treatment resistance
Central European Journal of Medicine, April 23, 2013
Exclusive Author Commentary
6 The Effect of Intensive Glucose Lowering on Lipoprotein Particle Profiles and Inflammatory Markers in the Veterans Affairs Diabetes Trial (VADT) Diabetes Care, April 1, 2013
7
The endocrinology of exercise
Internal and Emergency Medicine, March 27, 2013
Review Article
Exclusive Author Commentary
8 Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Hypertension, April 19, 2013
9 Effect of Ezetimibe on Major Atherosclerotic Disease Events and All-Cause Mortality The American Journal of Cardiology, February 21, 2013
10 Trends in Predicted 10-Year Risk of Coronary Heart Disease and Cardiovascular Disease among US Adults from 1999 to 2010 JACC - Journal of the American College of Cardiology, April 12, 2013
11 The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes Diabetic Medicine, April 18, 2013
12 Prospective Association of 25(OH)D with Metabolic Syndrome Clinical Endocrinology, March 8, 2013
13 Status of Cardiovascular Health in US Adolescents Circulation, April 10, 2013
14 Effect Of Hypolipidemic Treatment On Emerging Risk Factors In Mixed Dyslipidemia: A Randomized Pilot Trial European Journal of Clinical Investigation, April 19, 2013
15 Labile Hypertension: Characteristics of a Referred Cohort Clinical and Experimental Hypertension, April 8, 2013
16 Relationships Between Serum Adiponectin and Bone Density, Adiposity and Calcified Atherosclerotic Plaque in the African American-Diabetes Heart Study Journal of Clinical Endocrinology and Metabolism, April 2, 2013 Review Article
17 Prevalence of Unrecognized Diabetes Mellitus in Patients Admitted With Acute Coronary Syndrome Angiology, April 2, 2013
18 Safety and Effect of Very Low Levels of Low-Density Lipoprotein Cholesterol on Cardiovascular Events The American Journal of Cardiology, April 4, 2013
19 The next generation of novel low-density lipoprotein cholesterol-lowering agents: Proprotein convertase subtilisin/kexin 9 inhibitors Pharmacological Research , April 18, 2013
20 Severe Hypertriglyceridemia-Related Acute Pancreatitis Therapeutic Apheresis and Dialysis, March 1, 2013 Review Article
Indexed Journals in Endocrinology: Endocrinology, Journal of Endocrinology, Clinical Endocrinology, Diabetes more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close